Cargando…

Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study

Psychotic illnesses show variable responses to treatment. Determining the neurobiology underlying this is important for precision medicine and the development of better treatments. It has been proposed that dopaminergic differences underlie variation in response, with striatal dopamine synthesis cap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jauhar, Sameer, Veronese, Mattia, Nour, Matthew M, Rogdaki, Maria, Hathway, Pamela, Turkheimer, Federico E., Stone, James, Egerton, Alice, McGuire, Philip, Kapur, Shitij, Howes, Oliver D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331038/ https://www.ncbi.nlm.nih.gov/pubmed/29679071 http://dx.doi.org/10.1038/s41380-018-0042-4

Ejemplares similares

The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
por: Jauhar, Sameer, et al.
Publicado: (2019)

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
por: Jauhar, Sameer, et al.
Publicado: (2018)

M149. THE TOPOGRAPHY OF STRIATAL DOPAMINE AND SYMPTOMS IN PSYCHOSIS: AN INTEGRATIVE PET AND MRI STUDY
por: McCutcheon, Rob, et al.
Publicado: (2020)

Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans.
por: Jauhar, S, et al.
Publicado: (2017)

Correction: Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S., et al.
Publicado: (2018)

Correction: Regulation of dopaminergic function: An [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S, et al.
Publicado: (2019)

O3.5. TESTING THE DOPAMINE HYPOTHESIS OF PSYCHOSIS USING POSITRON EMISSION TOMOGRAPHIC IMAGING IN FIRST EPISODE BIPOLAR AFFECTIVE DISORDER AND SCHIZOPHRENIA
por: Jauhar, Sameer, et al.
Publicado: (2018)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study
por: McCutcheon, Robert A., et al.
Publicado: (2020)

S181. THE STATE OR TRAIT COMPONENT OF DOPAMINE AND GLUTAMATE DYSFUNCTION IN THE RISK FOR PSYCHOSIS: AN IN VIVO MULTIMODAL IMAGING STUDY OF INDIVIDUALS WITH 22Q11.2 DELETION
por: Rogdaki, Maria, et al.
Publicado: (2018)

The relationship between grey matter volume and striatal dopamine function in psychosis: a multi-modal (18)F-DOPA PET and voxel-based morphometry study
por: D’Ambrosio, Enrico, et al.
Publicado: (2021)

M18. REDUCED CORTICAL CEREBRAL BLOOD FLOW IN FIRST EPISODE PSYCHOSIS PATIENTS
por: Selvaggi, Pierluigi, et al.
Publicado: (2020)

Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study
por: Rogdaki, Maria, et al.
Publicado: (2021)

A potential biomarker for treatment stratification in psychosis: evaluation of an [(18)F] FDOPA PET imaging approach
por: Veronese, Mattia, et al.
Publicado: (2020)

The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A (1)H-MRS study in first-episode psychosis patients
por: Zahid, Uzma, et al.
Publicado: (2022)

Reduced cortical cerebral blood flow in antipsychotic-free first-episode psychosis and relationship to treatment response
por: Selvaggi, Pierluigi, et al.
Publicado: (2023)

F180. CANNABINOID 1 RECEPTOR AVAILABILITY & MEMORY FUNCTION IN FIRST EPISODE PSYCHOSIS: A MULTI-MODAL PET-FMRI STUDY
por: Borgan, Faith, et al.
Publicado: (2018)

N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study
por: Borgan, Faith R., et al.
Publicado: (2019)

S172. GLUTAMATE RELATED CONNECTIVITY DISTURBANCES OF THE SALIENCE AND DEFAULT MODE NETWORKS IN PSYCHOSIS
por: McCutcheon, Rob, et al.
Publicado: (2020)

Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning
por: Pontoriero, Antonella D., et al.
Publicado: (2021)

The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life
por: Froudist-Walsh, Sean, et al.
Publicado: (2017)

An automatic analysis framework for FDOPA PET neuroimaging
por: Nordio, Giovanna, et al.
Publicado: (2023)

Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
por: Pillinger, Toby, et al.
Publicado: (2019)

S145. ANTIPSYCHOTIC DISCONTINUATION IN FIRST EPISODE PSYCHOSIS: [18F]DOPA AND [11C]RACLOPRIDE PET STUDY
por: Kim, Euitae
Publicado: (2018)

N-Methyl-D-Aspartate Receptor availability in First-Episode Psychosis: a multi-modal PET-MR brain imaging study
por: Beck, K., et al.
Publicado: (2022)

Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
por: Townsend, Leigh, et al.
Publicado: (2023)

Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young People
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

N-Methyl-D-Aspartate Receptor binding in First-Episode Psychosis: A PET brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study
por: Rogeau, Antoine, et al.
Publicado: (2022)

Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study
por: Borgan, Faith, et al.
Publicado: (2020)

Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
por: Modinos, Gemma, et al.
Publicado: (2021)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

Are we getting any better at staying better? The long view on relapse and recovery in first episode nonaffective psychosis and schizophrenia
por: Taylor, Mark, et al.
Publicado: (2019)

Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study
por: Howes, Oliver D., et al.
Publicado: (2019)

Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study
por: McCutcheon, Robert A., et al.
Publicado: (2019)

Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
por: Oliver, Dominic, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iu6m0i91o79dbgl0ust2uoghd7